Anti-Glial Fibrillary Acidic Protein (GFAP) AntibodySKU: GFAPVolume: 200 ??LSpecies Reactivity…

The University of Virginia awarded contract A207_PO-0445541-V3 to Antibodies Inc. on August 8, 2026, for the supply of Anti-Glial Fibrillary Acidic Protein (GFAP) antibodies. The contract encompasses a total cumulative value of $301 and involves the delivery of 301 units of GFAP antibody product to the contracting organization in Virginia. GFAP antibodies are research reagents with demonstrated reactivity across multiple species including human, mouse, non-human primate, and rat, with documented applications in flow cytometry, immunocytochemistry (ICC), immunohistochemistry (IHC), and Western blot (WB) analyses.

The line item specifies delivery of Anti-GFAP antibodies produced in chicken host species at a volume of 200 microliters per unit. As the prime contractor, Antibodies Inc. is responsible for fulfilling the purchase order requirements and delivering the ordered antibody products to the University of Virginia buyer. The contract represents a standard procurement of laboratory research materials by an academic institution for use in scientific research and diagnostic applications.